Literature DB >> 1980373

Effects of chronic treatments with amineptine and desipramine on motor responses involving dopaminergic systems.

A Chagraoui1, M Vasse, P Protais.   

Abstract

The acute effects of increasing doses of the antidepressant drugs amineptine (5-40 mg/kg, IP) and desipramine (5-20 mg/kg IP) were studied in mice on three parameters of the activity (the horizontal activity, the vertical activity and the number of small movements without displacement) measured in a computerized Digiscan actimeter. The horizontal and vertical activities were dose dependently and similarly increased by acute amineptine, whereas the number of movements without displacement was increased up to 10 mg/kg with no further significant modification up to 40 mg/kg; in contrast, all three parameters were reduced in an identical manner by desipramine. The changes in the responses to the selective D-1 dopamine (DA) receptor agonist SK&F 38393 (1.87-30 mg/kg, SC), to the selective D-2 DA receptor agonist LY 171555 (0.1-1.6 mg/kg, SC) and to the selective DA uptake inhibitor GBR 12783 (1.25-20 mg/kg, IP) were measured on the three parameters of activity in mice chronically treated with amineptine (20 mg/kg, IP twice daily during 15 days) or by desipramine (10 mg/kg, IP, twice daily during 15 days). The chronic treatments with amineptine or desipramine did not modify the motor stimulant effects GBR 12783 and of SK&F 38393 on the three parameters (excepted for a slight modification of the horizontal activity for 7.5 mg/kg SK&F 38393 in mice chronically treated with amineptine). In contrast, the motor inhibitory effects of the lowest doses of LY 171555 (0.1-0.4 mg/kg) were strongly reduced in mice chronically treated with amineptine or desipramine but only on the horizontal activity with no change on the vertical activity and on the number of small movements without displacement.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980373     DOI: 10.1007/bf02245922

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

2.  Chronic imipramine administration reduces apomorphine inhibitory effects.

Authors:  C Scavone; M L Aizenstein; R De Lucia; C Da Silva Planeta
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

3.  Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment.

Authors:  F T Crews; C B Smith
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

4.  Repeated treatment with imipramine decreased the number of [3H]piflutixol binding sites in the rat striatum.

Authors:  V Klimek; M Nielsen; J Maj
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

5.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.

Authors:  K Tsuruta; E A Frey; C W Grewe; T E Cote; R L Eskay; J W Kebabian
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

6.  Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.

Authors:  S M Brudzyński; G J Mogenson
Journal:  Brain Res       Date:  1985-05-13       Impact factor: 3.252

7.  TL 333, a benzhydro[g]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptor.

Authors:  Y Itoh; M E Goldman; J W Kebabian
Journal:  Eur J Pharmacol       Date:  1985-01-15       Impact factor: 4.432

8.  Quinpirole hydrochloride, a potential anti-parkinsonism drug.

Authors:  W Koller; G Herbster; D Anderson; R Wack; J Gordon
Journal:  Neuropharmacology       Date:  1987-08       Impact factor: 5.250

9.  High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.

Authors:  J J Bonnet; P Protais; A Chagraoui; J Costentin
Journal:  Eur J Pharmacol       Date:  1986-07-31       Impact factor: 4.432

10.  Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.

Authors:  G L Diggory; W R Buckett
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

View more
  1 in total

1.  Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice.

Authors:  E Tirelli; P Terry
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.